Haemophilus influenzae type b exoproducts induce chemotaxis and macrolide antibiotic release by human polymorphonuclear leukocytes

Chemotherapy

Volumn 42, Issue 1, 1996, Pages 71-77

  Fontán, Patricia A ^a   Buzzola, Fernanda R ^a   Spinedi, Emma G ^a   Sordelli, Daniel O ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Haemophilus influenzae; Macrolide antibiotics; Polymorphonuclear leukocytes

Indexed keywords

AGAR; AGAROSE; AZITHROMYCIN; ERYTHROMYCIN; MACROLIDE;

AGAR GEL DIFFUSION; ARTICLE; BACTERIUM CULTURE; BIOASSAY; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CONCENTRATION; DRUG TRANSPORT; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; SUPERNATANT;

ANTIBIOTICS, MACROLIDE; AZITHROMYCIN; CHEMOTAXIS, LEUKOCYTE; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE; HUMAN; NEUTROPHILS; SUPPORT, NON-U.S. GOV'T;

EID: 0029655954     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239424     Document Type: Article

References (17)

1. Lode H: The pharmacokinetics of azithromycin and their clinical significance. Eur J Clin Microbiol Infect Dis 1991;10:807-812.
2. Gladue RP, Bright GM, Isaacson RE, Newborg ME: In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: Possible mechanism of delivery and release at sites of infection. Anlimicrob Agents Chemother 1989:33:277-282.
3. Cundell DR, Taylor GW, Kantha-kumar K, Wilks M, Tabaqchali S, Dorey E, Devalia JL, Roberts DR, Davies RJ, Wilson R, Cole PJ: Inhibition of human neutrophil migration in vitro by low-molecular-mass products of nontypcable Haemophilus influenzae.Infect Immun 1993: 61:2419-2424.
4. Metcalf JA, Gallin JI, Nauseef WM, Root RK: Preparation of cells and materials for functional assays: in Metcalf JA. Gallin Jl, NauseefWM. Root RK (eds): Laboratory Manual of Neutrophil Function. New York, Raven Press, 1986, pp 2-29.
5. Sahnt DF, Washington JA II: Antibacterial susceptibility tests: Dilution methods: in BalowsA. Haussier WJ. Herrmann KL, Isenberg HD, Shadomy IT J (eds): Manual of Clinical Microbiology, Washington, American Society for Microbiology, 1991. pp 1105-1116.
6. Girard AE, Girard D, English AR, Gootz TD, Cimochowski CR. Faiel-la JA. Haskell SL, Retsema JA: Pharmacokinetic and in vivo studies with azithromycin (CP-62.993), a new macrolide with an extended half-life and excellent tissue distribution. Anlimicrob Agents Chemother 1987.31:1948-1954.
7. Harvath L, Falk W, Leonard EJ: Rapid quantitation of neutrophil Chemotaxis: Use of polyvinylpyrrolidone-free membrane in a multiwell assembly. J Immunol Methods 1980;37:39-44.
8. Fontân PA, Sordelli DO: A spectro-photometric micromcthod to assess polymorphonuclear leukocyte migration induced by bacterial chemo-tactins in a multi-microwcll Boyden chamber assembly. J Microbiol Methods 1989;10:225-230.
9. Frank MO, Sullivan GW, Carper HT, Mandell GL: In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. Anlimicrob Agents Chemother 1992:36:2584-2588.
10. McDonald PJ, Pruul H: Phagocyte uptake and transport of azithromycin. Eur J Clin Microbiol Infect Dis 1991;10:828-833.
11. Vallée E, Azoulav-Dupuis E, Poci-dalo JJ. Bergogne-Bérézin E: Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. Anti-microb Agents Chemother 1992;36: 1412-1417.
12. Fiese EF, Steffen SH: Comparison of acid stability of azithromycin and erythromycin. J Antimicrob Chemother 1990;25(suppl A):39-47.
13. Maskell JP, Sefton AM, Williams JD: Comparative in vitro activity of azithromycin and erythromycin against gram-positive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Chemother 1990:25: 19-24.
14. Nelson S, Summer WR, Terry PB. Warr GA, Jakab GJ: Erythromycin-induced suppression of pulmonary antibacterial defenses: A potential mechanism of supcrinfection in the lung. Am Rev Respir Dis 1987;136: 1207-1212.
15. Torre D, Broggini M, Botta V, Sam-pielro C, Busarcllo R, Garberi C: In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes. J Chemother 1991:3:236-239.
16. Ichikawa Y, Ninontiya H, Koga H, Tanaka M, Kinoshita M, Tokunaga N, Yano T, Oizumi E: Erythromycin reduces neutrophils and neutrophil-derived clastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992:146:196-203.
17. Anderson R: Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis 1989; 159:966-973.